InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: Amatuer17 post# 217205

Tuesday, 02/13/2018 7:07:12 AM

Tuesday, February 13, 2018 7:07:12 AM

Post# of 403739
“With the positive observation of intra-tumor p53 modulation, the Company will now allocate resources to focus its efforts on completing development of an oral formulation, including performing bridging toxicology work.”

Again, this is fact from company. They are focused on K and Oral formulation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News